Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus (Q28379074)
scientific article published on August 1, 1997
Language:
(P31) (Q13442814)
(P304) 1662-1667
(P407) (Q1860)
(P433) 8
(P478) 41
(P577) Friday, August 1, 1997
Friday, August 1, 1997
(P921) (Q595158)
(Q424027)
(Q424193)
(Q188121)
(P953) https://aac.asm.org/content/aac/41/8/1662.full.pdf
http://intl-aac.asm.org/cgi/content/abstract/41/8/1662
https://europepmc.org/articles/PMC163981
https://europepmc.org/articles/PMC163981?pdf=render
https://journals.asm.org/doi/pdf/10.1128/AAC.41.8.1662
(P1433) (Q578004)
(P1476) "Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus" (language: en)
(P2093) J. M. Entenza
J. Vouillamoz
M. P. Glauser
P. Moreillon
(P2860) (Q24671010)
(Q41254190)
(Q40284884)
(Q33753316)
(Q33753017)
(Q40513454)
(Q40390211)
(Q39780047)
(Q35115756)
(Q34288403)
(Q35675005)
(Q36328909)
(Q39850799)
(Q35310537)
(Q37900073)
(Q35563775)
(Q39814859)
(Q39952058)
(Q51634358)
(Q44996002)
(Q67717640)
(Q71373509)
(Q70592708)
other details
description scientific article published on August 1, 1997

External Links